About US
Contact us
-
Pharmaxis receives FDA approval to market ARIDOL Test KitPharmaxis, a global specialty pharmaceutical company focused on therapeutic products for chronic respiratory and immune disorders, announced today that it has received approval from the U.S. Food and2010/10/8
-
Roche receives development and commercialization rights for danoprevir drugInterMune, Inc. (Nasdaq: ITMN) today announced that it has sold worldwide development and commercialization rights to danoprevir (also known as RG7227 or ITMN-191) to Hoffman-La Roche Inc. and F. Hoff2010/10/8
-
USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tabletsSun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted a tentative approval for its Abbreviated New Drug Application2010/9/30
-
Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discoveryLigon Discovery, the innovator of Small Molecule Microarray technology, today announced that it has partnered with Bayer Schering Pharma AG, Germany, to apply its proprietary Small Molecule Microarray2010/9/30
-
China tightens restrictions on online transactions of drug precursor chemicalsThe Chinese government issued a circular Monday (September 27, 2010) to tighten restrictions on online transactions of drug precursor chemicals, in a bid to fight Internet-enabled drug trafficking.Acc2010/9/29
-
SFDA releases 2009 Annual Report on Drug Registration ApprovalThe State Food and Drug Administration (SFDA) recently officially released the 2009 Annual Report on Drug Registration Approval. The Annual Report consists of six parts: the drug registration manageme2010/9/29
-
FDA approves combination contraceptive containing a folateThe U.S. Food and Drug Administration today approved Beyaz tablets, an estrogen/progestin combined oral contraceptive that also contains a folate (levomefolate calcium 0.451 mg). Levomefolate calci2010/9/28
-
FDA significantly restricts access to the diabetes drug AvandiaMakes regulatory decisions on RECORD and TIDE trials The U.S. Food and Drug Administration today announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone)2010/9/28
-
BASF increases prices for automotive fluids globallyBASF increases prices for automotive fluids globally Ludwigshafen, Germany – September 24, 2010 – With immediate effect, or as contracts allow, BASF is increasing the sales prices globally for all2010/9/27
-
AVENEER® - Construction of the first MMA production plant slated for 2014 – location to be decided on in 2011AVENEER® - Construction of the first MMA production plant slated for 2014 – location to be decided on in 2011 Catalytic process improves ACH yield by up to 10 percent AVENEER® reduces2010/9/27